Cargando…

DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors

Management of localized well-differentiated pancreatic neuroendocrine tumors (panNETs) is controversial and primarily dependent on tumor size. Upfront surgery is usually recommended for tumors larger than 2 cm in diameter since they frequently show metastatic potential, whereas smaller panNETs are g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cives, Mauro, Partelli, Stefano, Palmirotta, Raffaele, Lovero, Domenica, Mandriani, Barbara, Quaresmini, Davide, Pelle’, Eleonora, Andreasi, Valentina, Castelli, Paola, Strosberg, Jonathan, Zamboni, Giuseppe, Falconi, Massimo, Silvestris, Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901561/ https://www.ncbi.nlm.nih.gov/pubmed/31819132 http://dx.doi.org/10.1038/s41598-019-55156-0

Ejemplares similares

Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
por: Cives, Mauro, et al.
Publicado: (2020)

Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors
por: Mandriani, Barbara, et al.
Publicado: (2022)

Nutrition and Female Fertility: An Interdependent Correlation
por: Silvestris, Erica, et al.
Publicado: (2019)

Osteotropism of neuroendocrine tumors: role of the CXCL12/CXCR4 pathway in promoting EMT in vitro
por: Cives, Mauro, et al.
Publicado: (2017)

Long-Term Pancreatic Functional Impairment after Surgery for Neuroendocrine Neoplasms
por: Andreasi, Valentina, et al.
Publicado: (2019)

Rare Dihydropyrimidine Dehydrogenase Variants and Toxicity by Floropyrimidines: A Case Report
por: Palmirotta, Raffaele, et al.
Publicado: (2019)

Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition
por: Palmirotta, Raffaele, et al.
Publicado: (2016)

What is the role of checkpoint inhibitors in neuroendocrine neoplasms?
por: Al-Toubah, Taymeyah, et al.
Publicado: (2020)

Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art
por: Gentile, Marica, et al.
Publicado: (2020)

DEAD-Box Helicase 4 (Ddx4)(+) Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers
por: D’Oronzo, Stella, et al.
Publicado: (2020)

Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis
por: Tucci, Marco, et al.
Publicado: (2020)

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations
por: Rizzo, Francesca Maria, et al.
Publicado: (2016)

Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification
por: Tacelli, Matteo, et al.
Publicado: (2021)

Liquid Biopsy in Cervical Cancer: Hopes and Pitfalls
por: Cafforio, Paola, et al.
Publicado: (2021)

Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?
por: Massironi, Sara, et al.
Publicado: (2022)

Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer
por: D’Oronzo, Stella, et al.
Publicado: (2019)

Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours
por: Pipinikas, Christodoulos P, et al.
Publicado: (2015)

Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study
por: Partelli, Stefano, et al.
Publicado: (2020)

Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications
por: Lauricella, Eleonora, et al.
Publicado: (2022)

Surgical management of pancreatic neuroendocrine neoplasms
por: Partelli, Stefano, et al.
Publicado: (2014)

Laparoscopic Enucleation of a Nonfunctioning Neuroendocrine Tumor of the Pancreas
por: Kang, Chang Moo, et al.
Publicado: (2008)

Extended surgical resection for nonfunctioning duodenal neuroendocrine tumor
por: Lucandri, Giorgio, et al.
Publicado: (2022)

Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology
por: Crippa, Stefano, et al.
Publicado: (2016)

DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors
por: Park, Joo Kyung, et al.
Publicado: (2017)

Laparoscopic Enucleation of a Nonfunctioning Neuroendocrine Tumor at the Head of the Pancreas
por: Singh, Nikhil, et al.
Publicado: (2006)

Evaluation of Survival Following Surgical Resection for Small Nonfunctional Pancreatic Neuroendocrine Tumors
por: Sugawara, Toshitaka, et al.
Publicado: (2023)

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
por: Mapelli, Paola, et al.
Publicado: (2021)

Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis
por: Wang, Fei, et al.
Publicado: (2021)

Multiple Cardiac Metastases from a Nonfunctioning Pancreatic Neuroendocrine Tumor
por: Choi, Yong Hyeok, et al.
Publicado: (2013)

Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs)
por: Jung, Jae Gu, et al.
Publicado: (2015)

Nonfunctional pancreatic neuroendocrine tumor masked as anemia: A case report
por: Xu, Baojin, et al.
Publicado: (2017)

Minimally invasive vs open pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors
por: Kim, Juwan, et al.
Publicado: (2020)

Insights of Outcome after Resection of Small Nonfunctioning Neuroendocrine Pancreatic Tumors
por: Figueira, Estela Regina Ramos, et al.
Publicado: (2021)

Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms
por: Shintakuya, Ryuta, et al.
Publicado: (2023)

Management of Small Nonfunctioning Pancreatic Neuroendocrine Neoplasms: Current Opinion and Controversies
por: Paik, Woo Hyun, et al.
Publicado: (2022)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
por: Pergolini, I., et al.
Publicado: (2019)

EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)
por: April-Monn, Simon Leonhard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_upbqv8i20iqg459m21ch10pera